Abstract

Dear Editor:
Thank-you to Dr Tenforde for the useful comments about the study of the effectiveness of shockwave in chronic insertional Achilles tendinopathy that was published recently. 5 Answering a number of methodologic issues would be helpful for readers to make a decision in the use of shockwave for chronic insertional Achilles tendinopathy. Our response to your points 1 to 5,
Type of shockwave device
In our study, we used 4 courses of radial shockwave with 240 to 320 J/mm2 energy flux density (EFD) for the treatment of chronic insertional Achilles tendinopathy per the protocol of Rompe
7
which showed an improvement in visual analog scale (VAS) score. In another study by Rompe
6
that classified shockwave into 3 groups based on EFD—low (<0.08 mJ/mm2), medium (<0.28 mJ/mm2), and high (<0.60 mJ/mm2)—the study showed that low and medium EFD had positive effects on pain relief and tendon healing whereas Chao et al
1
revealed that a higher energy level had significant inhibitory effects on tenocyte proliferation and extracellular matrix metabolism. According to Furia et al,
3
the use of single-dose, high-energy, focus shockwave (604 J/mm2) might have inhibitory effects on tendon healing and using anesthesia to avoid discomfort to the patient during operation might cause confounding of the results. Insertional Achilles calcification was commonly found in chronic insertional Achilles tendinopathy (65%-80% in Kang et al,
4
100% in our study). In the study by Rompe et al,
7
patients who presented with Haglund deformity were excluded, but the authors did not mention if patients with insertional Achilles calcification were excluded. In addition, Haglund deformity had no significant clinical correlation to insertional Achilles tendinopathy because it could be found in asymptomatic patients,
4
so it might not confound the effect of extracorporeal shockwave therapy (ESWT) on insertional Achilles tendinopathy.
Clinical focusing
We also use the clinical focusing technique by applying the shockwave probe at the point of maximum tenderness of the Achilles tendon insertion and circumferential area within 2 × 2 cm2. It usually created pain during the procedure in the shockwave group as you comment, but the 2 patients in our study who experienced pain could not tolerate it and asked to withhold the procedure and resume when the pain had subsided. We had to use the lowest energy they could tolerate but not less than our shockwave protocol prescribes.
Standardized loading program
Because of low patient satisfaction (32%) of traditional eccentric exercise for insertional Achilles tendinopathy
2
and no Level I evidence evaluated the effectiveness of modified eccentric exercise protocol in chronic insertional Achilles tendinopathy and we wanted to evaluate the real effectiveness of ESWT, so we did not include eccentric exercise into standard conservative treatments because that might confound the result.
Outcome measures
We used the Visual Analog Scale Foot and Ankle score (VAS-FA) because it had been validated in comparison to SF-36 in its Thai version, which patients in our study could complete it by themselves. Although VAS-FA had less specificity to Achilles tendinopathy than VISA-A, but it had 20 questions (3 categories: pain 4 questions, function 11 questions, and other complaints 5 questions) that covered most foot and ankle problems, including Achilles tendinopathy. Moreover, VISA-A has not been validated in the Thai version precluding proper outcome evaluation.
Rescue medications
We used nonsteroidal anti-inflammatory drugs as rescue drug because it was a standard medication for insertional Achilles tendinopathy. Theoretically, it may reduce efficacy in disrupting healing as you mentioned, but a few of our patients had used Naproxen for pain relief although not for a long period, and the healing had still occurred.
Our study found no significant difference between the ESWT and sham group outcomes in chronic insertional Achilles tendinopathy at 24 weeks. Two points of concern were the age of the patients in our study, which was about 60 years, and could indicate a low potential for tendon healing; in addition, all patients had insertional calcification, which might indicate the severity of disease that could not benefit from ESWT. Further studies to evaluate the effectiveness of ESWT in calcific and noncalcific tendon insertion group or in young as well as old age groups would be useful.
Supplemental Material
FAI925753_disclosures – Supplemental material for Response to “Letter Regarding: Effectiveness of Extracorporeal Shockwave Therapy in the Treatment of Chronic Insertional Achilles Tendinopathy”
Supplemental material, FAI925753_disclosures for Response to “Letter Regarding: Effectiveness of Extracorporeal Shockwave Therapy in the Treatment of Chronic Insertional Achilles Tendinopathy” by Siwadol Pinitkwamdee in Foot & Ankle International
Footnotes
Declaration of Conflicting Interests
The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. ICMJE forms for all authors are available online.
Funding
The author received no financial support for the research, authorship, and/or publication of this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
